KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2.

ABSTRACT:

SUBMITTER: Wang Q 

PROVIDER: S-EPMC12181982 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature